Xuanzhu’s Xuanyuening Approved for 2 Indications in China
15 May 2025 //
PR NEWSWIRE
Innovent and Xuanzhu Enter into Clinical Trial Collaboration
27 Dec 2023 //
PR NEWSWIRE
Xuanzhu Biopharm, a subsidiary of Sihuan, Its Innovative Drug Anaprozole Sodium
27 Jun 2023 //
PR NEWSWIRE
Xuanzhu and SignalChem Lifesciences announce collaboration for SLC-391
27 Sep 2021 //
FIRSTWORDPHARMA
Xuanzhu and SignalChem Announce Collaboration & Licensing Agreement for SLC-391
23 Sep 2021 //
EINNEWS